Expectations, end-of-life fears and end-of-life communication among palliative patients with cancer and caregivers: a cross-sectional study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
11 05 2022
Historique:
entrez: 11 5 2022
pubmed: 12 5 2022
medline: 18 5 2022
Statut: epublish

Résumé

During serious illness, open communication with caregivers can ensure high-quality care. Without end-of-life communication, caregivers may become surrogates and decision-makers without knowing the patient's preferences. However, expectations and fears may influence the initiation of communication. The present study investigates differences between palliative patients with cancer and caregivers regarding expectations of end-of-life communication, end-of-life fears and experiences with end-of-life communication. A cross-sectional study using a semi-structured interview and a paper-based questionnaire SETTING: University Hospital in Germany. 151 participants: 85 palliative cancer patients (mean age: 62.8 years, 65.9% male) and 66 caregivers (mean age: 56.3 years, 28.8% male). Expectations, end-of-life fears and experiences of end-of-life discussions. Patients and caregivers wish for the patient to be self-determined. In general, participants reported more positive than negative expectations of end-of-life discussions. Importantly, concerns about emotionally burdening other person was rated much higher in an informal context than a professional context (F(1,149)=316 958, p<0.001, η There seems to exist a 'self-other' asymmetry: palliative patients and their caregivers expect substantial personal relief when openly talking about end-of-life issues, but also expect the other person to be burdened by such communication. Professionals repeatedly need to initiate end-of-life communication.

Identifiants

pubmed: 35545378
pii: bmjopen-2021-058531
doi: 10.1136/bmjopen-2021-058531
pmc: PMC9096546
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e058531

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J Gen Intern Med. 1994 Oct;9(10):539-43
pubmed: 7823223
Death Stud. 2004 May;28(4):309-40
pubmed: 15129688
Psychother Psychosom. 2017;86(1):13-30
pubmed: 27884006
Front Psychol. 2017 Feb 21;8:233
pubmed: 28270786
J Pain Symptom Manage. 2017 Jul;54(1):17-26.e1
pubmed: 28450216
Ann Intern Med. 2011 Mar 1;154(5):336-46
pubmed: 21357911
Support Care Cancer. 2014 Oct;22(10):2775-82
pubmed: 24811216
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Psychooncology. 2013 Mar;22(3):555-63
pubmed: 22290823
BMC Cancer. 2013 Sep 18;13:426
pubmed: 24047450
Palliat Med. 2016 Sep;30(8):772-9
pubmed: 26857360
J Psychosoc Oncol. 2012;30(3):347-58
pubmed: 22571248
Support Care Cancer. 2020 Oct;28(10):4667-4675
pubmed: 31955277
Lancet. 2004 Oct 16-22;364(9443):1421-7
pubmed: 15488217
Breast Cancer Res Treat. 2018 Apr;168(3):667-677
pubmed: 29330625
Death Stud. 2004 Nov;28(9):829-48
pubmed: 15493077
Curr Opin Psychiatry. 2015 Sep;28(5):378-85
pubmed: 26164612
J Clin Oncol. 2010 Mar 1;28(7):1203-8
pubmed: 20124172
J Pain Symptom Manage. 2017 May;53(5):862-870
pubmed: 28189769
CMAJ. 2004 Jun 8;170(12):1795-801
pubmed: 15184333
Eur J Oncol Nurs. 2020 Oct;48:101803
pubmed: 32836000
Psychother Psychosom. 2005;74(2):100-7
pubmed: 15741759
JAMA Intern Med. 2019 Feb 1;179(2):267-268
pubmed: 30477019
Psychother Psychosom. 2021;90(4):243-254
pubmed: 33212438
Psychooncology. 2013 Aug;22(8):1688-704
pubmed: 23045191
N Engl J Med. 2020 Feb 6;382(6):554-561
pubmed: 32023375
J Pain Symptom Manage. 2015 Jun;49(6):1070-80
pubmed: 25623923
Soc Psychiatry Psychiatr Epidemiol. 2010 Feb;45(2):153-63
pubmed: 19381427
Psychooncology. 2016 Nov;25(11):1278-1285
pubmed: 26632424
Qual Life Res. 2003;12 Suppl 1:33-41
pubmed: 12803309
Annu Rev Psychol. 2019 Jan 4;70:599-625
pubmed: 30110575
BMC Health Serv Res. 2020 May 11;20(1):408
pubmed: 32393244
JAMA. 2008 Oct 8;300(14):1665-73
pubmed: 18840840
Health Commun. 2009 Sep;24(6):524-31
pubmed: 19735030

Auteurs

Pia von Blanckenburg (P)

Department of Clinical Psychology and Psychotherapy, Philipps-Universität Marburg, Marburg, Germany blanckep@staff.uni-marburg.de.

Jorge Riera Knorrenschild (J)

Department of Internal Medicine, Division of Haematology and Oncology, Philipps-Universität Marburg Fachbereich Medizin, Marburg, Germany.

Mareike Hofmann (M)

Department of Clinical Psychology and Psychotherapy, Philipps-Universität Marburg, Marburg, Germany.

Hansjakob Fries (H)

Department of Internal Medicine III - Oncology, Hematology and Rheumatology, University Hospital Bonn, Bonn, Germany.

Yvonne Nestoriuc (Y)

Department of Clinical Psychology, Helmut-Schmidt-Universität, Hamburg, Germany.
Department of Systems Neuroscience, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Ulf Seifart (U)

Rehabilitation Clinic Sonnenblick, Marburg, Germany.

Winfried Rief (W)

Department of Clinical Psychology and Psychotherapy, Philipps-Universität Marburg, Marburg, Germany.

Carola Seifart (C)

Department of Medicine, Research Group Medical Ethics, Philipps-Universität Marburg, Marburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH